While there is compelling evidence that KCNK3 is involved in pathogenesis of PAH in humans [13–15], the mouse does not appear to serve as a suitable model for studying the underlying molecular mechanisms. This evidence concerns the gene KCNK3 and pulmonary arterial hypertension.